Suppr超能文献

难治性高血压的检查与治疗方法

Resistant hypertension workup and approach to treatment.

作者信息

Makris Anastasios, Seferou Maria, Papadopoulos Dimitris P

机构信息

European Excellent Center of Hypertension, Laiko University Hospital, 24 Agiou Ioannou Theologou Street, 155-61 Athens, Greece.

出版信息

Int J Hypertens. 2010 Dec 26;2011:598694. doi: 10.4061/2011/598694.

Abstract

Resistant hypertension is defined as blood pressure above the patient's goal despite the use of 3 or more antihypertensive agents from different classes at optimal doses, one of which should ideally be a diuretic. Evaluation of patients with resistive hypertension should first confirm that they have true resistant hypertension by ruling out or correcting factors associated with pseudoresistance such as white coat hypertension, suboptimal blood pressure measurement technique, poor adherence to prescribed medication, suboptimal dosing of antihypertensive agents or inappropriate combinations, the white coat effect, and clinical inertia. Management includes lifestyle and dietary modification, elimination of medications contributing to resistance, and evaluation of potential secondary causes of hypertension. Pharmacological treatment should be tailored to the patient's profile and focus on the causative pathway of resistance. Patients with uncontrolled hypertension despite receiving an optimal therapy are candidates for newer interventional therapies such as carotid baroreceptor stimulation and renal denervation.

摘要

顽固性高血压的定义为,尽管已使用3种或更多不同种类的降压药物且剂量达到最佳,其中理想的一种应为利尿剂,但患者血压仍高于目标值。对顽固性高血压患者进行评估时,应首先通过排除或纠正与假性耐药相关的因素(如白大衣高血压、血压测量技术欠佳、对规定药物依从性差、降压药物剂量欠佳或组合不当、白大衣效应及临床惰性)来确认患者是否患有真正的顽固性高血压。治疗措施包括生活方式和饮食调整、停用导致耐药的药物以及评估高血压的潜在继发原因。药物治疗应根据患者情况量身定制,并聚焦于耐药的致病途径。尽管接受了最佳治疗但血压仍未得到控制的患者,可考虑采用更新的介入治疗方法,如颈动脉压力感受器刺激术和肾去神经术。

相似文献

1
Resistant hypertension workup and approach to treatment.
Int J Hypertens. 2010 Dec 26;2011:598694. doi: 10.4061/2011/598694.
2
Management of resistant hypertension.
Curr Opin Cardiol. 2019 Jul;34(4):367-375. doi: 10.1097/HCO.0000000000000635.
3
Evaluation and Management of Resistant Hypertension: Core Curriculum 2024.
Am J Kidney Dis. 2024 Sep;84(3):374-387. doi: 10.1053/j.ajkd.2024.04.009. Epub 2024 Jul 20.
5
Resistant Hypertension Updated Guidelines.
Curr Cardiol Rep. 2019 Aug 30;21(10):117. doi: 10.1007/s11886-019-1209-6.
6
Management of Resistant Hypertension.
Annu Rev Med. 2024 Jan 29;75:443-457. doi: 10.1146/annurev-med-050922-052605. Epub 2023 Sep 22.
7
[Resistant hypertension: evaluation and treatment].
Presse Med. 2009 Apr;38(4):643-51. doi: 10.1016/j.lpm.2009.02.004. Epub 2009 Mar 17.

引用本文的文献

1
Approaches and Challenges in Managing Treatment-Resistant Hypertension: A Case Report.
Cureus. 2024 Dec 11;16(12):e75554. doi: 10.7759/cureus.75554. eCollection 2024 Dec.
2
Case Report: Segmental Arterial Mediolysis, a Rare Cause of Hypertension.
Can J Kidney Health Dis. 2020 Aug 19;7:2054358120950885. doi: 10.1177/2054358120950885. eCollection 2020.
3
Critical Analysis of Cardiovascular and Central Nervous System Fixed Dose Combinations Available in Indian Market.
J Clin Diagn Res. 2016 Dec;10(12):FC36-FC39. doi: 10.7860/JCDR/2016/21515.9049. Epub 2016 Dec 1.
5
Treating resistant hypertension: role of renal denervation.
Integr Blood Press Control. 2013 Sep 11;6:119-28. doi: 10.2147/IBPC.S33958.
6
Role of single-pill combination therapy in optimizing blood pressure control in high-risk hypertension patients and management of treatment-related adverse events.
J Clin Hypertens (Greenwich). 2012 Oct;14(10):718-26. doi: 10.1111/j.1751-7176.2012.00696.x. Epub 2012 Aug 13.
7
Treatment strategies for resistant arterial hypertension.
Dtsch Arztebl Int. 2011 Oct;108(43):725-31. doi: 10.3238/arztebl.2011.0725. Epub 2011 Oct 28.

本文引用的文献

1
New therapeutic approaches to resistant hypertension.
Curr Hypertens Rep. 2010 Aug;12(4):296-302. doi: 10.1007/s11906-010-0119-1.
2
Implantable carotid sinus stimulator for the treatment of resistant hypertension: local effects on carotid artery morphology.
Ann Vasc Surg. 2010 Feb;24(2):178-84. doi: 10.1016/j.avsg.2009.10.003. Epub 2009 Dec 29.
3
Renal sympathetic-nerve ablation for uncontrolled hypertension.
N Engl J Med. 2009 Aug 27;361(9):932-4. doi: 10.1056/NEJMc0904179.
4
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.
Lancet. 2009 Apr 11;373(9671):1275-81. doi: 10.1016/S0140-6736(09)60566-3. Epub 2009 Mar 28.
6
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.
7
Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis.
Hypertension. 2008 Sep;52(3):522-8. doi: 10.1161/HYPERTENSIONAHA.108.113068. Epub 2008 Aug 11.
9
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.
Lancet. 2008 Jun 7;371(9628):1921-6. doi: 10.1016/S0140-6736(08)60834-X.
10
Aliskiren combined with losartan in type 2 diabetes and nephropathy.
N Engl J Med. 2008 Jun 5;358(23):2433-46. doi: 10.1056/NEJMoa0708379.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验